InnoCare Pharma HK$2.24 billion IPO
Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Zhenro Properties Group $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 5.6% senior notes due 2021.
Zhenro Properties Group…
Zai Lab $300 million follow-on offering of ADSs
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
Dexin China Holdings $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Dexin China Holdings Company Limited of $200 million 11.875% senior notes due 2022.
Dexin China…
SOCAM Development $180 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $180 million Regulation S offering by SOCAM Development Limited of its 6.25% senior notes due 2022.
SOCAM Development Limited…
I-Mab $103.7 million IPO and Nasdaq listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by I-Mab of 7,407,400 American depositary shares, each 10 ADSs representing 23 ordinary shares, for total…
CIFI Holdings (Group) $167 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $167 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 6.0% senior notes due 2025. The notes are…
CIFI Holdings (Group) $400 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $400 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 6.00% senior notes due 2025.
Established in 2000…
Zhenro Properties Group $290 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $290 million 7.875% senior notes due 2024.
Zhenro Properties Group…
Davis Polk Advises Venus Medtech (Hangzhou) Inc. on Its HK$2.59 Billion (US$331.17 Million) Initial Public Offering
Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…